Published in
Elsevier, Biomedicine and Pharmacotherapy, (170), p. 116037, 2024
DOI: 10.1016/j.biopha.2023.116037
Links
Tools
The validation of new CHD1L inhibitors as a therapeutic strategy for cancer
Journal article published in 2024 by
Sophia Clune 
,
Paul Awolade ,
Qiong Zhou ,
Hector Esquer ,
Brock Matter ,
Kearns Jt,
Jeffrey T. Kearns,
Timothy Kellett ,
Damilola Caleb Akintayo,
Akintayo Dc,
Uday B. Kompella,
Kompella Ub,
LaBarbera Dv,
Daniel V. LaBarbera
,
Paul Awolade ,
Qiong Zhou ,
Hector Esquer ,
Brock Matter ,
Kearns Jt,
Jeffrey T. Kearns,
Timothy Kellett ,
Damilola Caleb Akintayo,
Akintayo Dc,
Uday B. Kompella,
Kompella Ub,
LaBarbera Dv,
Daniel V. LaBarbera
This paper is made freely available by the publisher.
Full text: Download
Data provided by 